Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of PXR activation by rifampicin on blood pressure regulation
2011-005522-22Phase 4Completed
- Sponsor
- Oulu University Hospital
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of rifampicin, sponsored by Oulu University Hospital. Primary endpoint: 24-hour ambulatory blood pressure and pulse changes. Started Jan 2012; status: completed.
02
Drugs
rifampicin
Beyond the preview
Go deeper on 2011-005522-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005522-22.